Literature DB >> 6145712

Dodecylglycerol. A new type of antibacterial agent which stimulates autolysin activity in Streptococcus faecium ATCC 9790.

H S Ved, E Gustow, V Mahadevan, R A Pieringer.   

Abstract

Dodecylglycerol has a minimum inhibitory concentration of 4 micrograms/ml compared to 9 micrograms/ml for monolaurin (dodecanoylglycerol) with Streptococcus faecium ATCC 9790 as the test organism. The greater potency of dodecylglycerol can be correlated to its greater retention by the cell. Gram-positive bacteria were more susceptible than Gram-negative bacteria to dodecylglycerol. The antibacterial action of dodecylglycerol is not through the physical dissolution of cell walls, but rather as an enzymatic effector. The autolysin activity of whole cells of S. faecium was greatly stimulated by dodecylglycerol. The stimulation of autolytic activity and inhibition of growth respond in parallel to different concentrations of dodecylglycerol, to dodecylglycerol versus some poorer effector such as monolaurin or a glycerol alkyl ether with a longer or shorter fatty alkyl side chain than dodecanol, and to the antagonistic effects of diphosphatidlyglycerol. This close relationship implies that the stimulation of autolysin activity could be a primary, but not necessarily the only, mechanism by which dodecylglycerol and related compounds exert their antibacterial activity. However, the autolysin activity is not stimulated by a direct interaction between the enzyme and dodecylglycerol. A non-wall entity, such as a proteinase, has been implicated as an intermediary (Ved, H. S., Gustow, E., and Pieringer, R. A. (1984) J. Biol. Chem. 259, 8122-8124).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145712

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Activation of macrophages by ether analogues of lysophospholipids.

Authors:  N Yamamoto; B Z Ngwenya; T W Sery; R A Pieringer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Lysis of Bacillus subtilis Cells by Glycerol and Sucrose Esters of Fatty Acids.

Authors:  T Tsuchido; Y H Ahn; M Takano
Journal:  Appl Environ Microbiol       Date:  1987-03       Impact factor: 4.792

3.  In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.

Authors:  Mark S Rouse; Margalida Rotger; Kerryl E Piper; James M Steckelberg; Matthew Scholz; Jeffrey Andrews; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 4.  Biosynthesis and biotransformation of ether lipids.

Authors:  H K Mangold; N Weber
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

5.  Use of resistant mutants to study the interaction of triton X-100 with Staphylococcus aureus.

Authors:  D Raychaudhuri; A N Chatterjee
Journal:  J Bacteriol       Date:  1985-12       Impact factor: 3.490

Review 6.  An update on the therapeutic role of alkylglycerols.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Mar Drugs       Date:  2010-08-05       Impact factor: 5.118

7.  Isolation and characterization of autolysis-defective mutants of Staphylococcus aureus created by Tn917-lacZ mutagenesis.

Authors:  N Mani; P Tobin; R K Jayaswal
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

8.  Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers.

Authors:  M P Haynes; H R Buckley; M L Higgins; R A Pieringer
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  A thioesterase bypasses the requirement for exogenous fatty acids in the plsX deletion of Streptococcus pneumoniae.

Authors:  Joshua B Parsons; Matthew W Frank; Marc J Eleveld; Joost Schalkwijk; Tyler C Broussard; Marien I de Jonge; Charles O Rock
Journal:  Mol Microbiol       Date:  2015-01-30       Impact factor: 3.501

10.  Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo.

Authors:  Ying-Chi Lin; Patrick M Schlievert; Michele J Anderson; Christina L Fair; Matthew M Schaefers; Ramaiah Muthyala; Marnie L Peterson
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.